{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:29:47Z","timestamp":1740122987126,"version":"3.37.3"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,3,30]],"date-time":"2019-03-30T00:00:00Z","timestamp":1553904000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Scientometrics"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s11192-019-03093-0","type":"journal-article","created":{"date-parts":[[2019,3,30]],"date-time":"2019-03-30T15:02:17Z","timestamp":1553958137000},"page":"1643-1654","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Historical analysis of pharmacoeconomic terms"],"prefix":"10.1007","volume":"119","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5336-3794","authenticated-orcid":false,"given":"Dominik","family":"Grega","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9046-3583","authenticated-orcid":false,"given":"Jozef","family":"Kol\u00e1\u0159","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,30]]},"reference":[{"issue":"3","key":"3093_CR1","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1177\/106002808201600307","volume":"16","author":"JL Bootman","year":"1982","unstructured":"Bootman, J. L., McGhan, W. F., & Schondelmeyer, S. W. (1982). Application of cost-benefit and cost-effectiveness analysis to clinical practice. Drug lntelligence and Clinical Pharmacy. 16(3), 235\u2013243.","journal-title":"Drug lntelligence and Clinical Pharmacy."},{"issue":"3","key":"3093_CR2","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1345\/aph.1G390","volume":"40","author":"JL Bootman","year":"2006","unstructured":"Bootman, J. L., McGhan, W. F., & Townsend, R. J. (2006). Pharmacoeconomics: Historical perspective. Annals of Pharmacotherapy, 40(3), 518\u2013519. https:\/\/doi.org\/10.1345\/aph.1G390 .","journal-title":"Annals of Pharmacotherapy"},{"key":"3093_CR3","volume-title":"Principles of pharmacoeconomics","author":"JL Bootman","year":"1991","unstructured":"Bootman, J. L., Townsend, R. J., & McGhan, W. F. (1991). Principles of pharmacoeconomics (1st ed.). Cincinnati, OH: Harvey Whitney Books Co.","edition":"1"},{"issue":"3","key":"3093_CR4","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1002\/jps.2600680304","volume":"68","author":"JL Bootman","year":"1979","unstructured":"Bootman, J. L., Wertheimer, A. I., Zaske, D., & Rowland, C. (1979). Individualizing gentamicin dosage regimens in burn patients with gram-negative septicemia: A cost-benefit analysis. Journal of Pharmaceutical Sciences, 68(3), 267\u2013272. https:\/\/doi.org\/10.1002\/jps.2600680304 .","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"3093_CR5","unstructured":"Dole\u017eal T. a kol (2007) Z\u00e1klady farmakoekonomiky pro l\u00e9ka\u0159e, l\u00e9k\u00e1rniky a dal\u0161\u00ed pracovn\u00edky ve zdravotnictv\u00ed (Fundamentals of pharmacoeconomics for doctors, pharmacists and other healthcare workers), 1st ed. Praha: \u010cFES."},{"key":"3093_CR6","volume-title":"Methods for the economic evaluation of health care programmes","author":"MF Drummond","year":"2015","unstructured":"Drummond, M. F., Sculpher, M. J., Claxton, K., Stoddard, G. L., & Torrance, G. W. (2015). Methods for the economic evaluation of health care programmes (4th ed.). Oxford: Oxford University Press.","edition":"4"},{"issue":"5","key":"3093_CR7","first-page":"MS1","volume":"36","author":"A Elixhauser","year":"1998","unstructured":"Elixhauser, A., Halpern, M., Schmier, J., & Luce, B. R. (1998). Health care CBA and CEA from 1991 to 1996: An updated bibliography. Medical Care, 36(5), MS1\u2013MS9.","journal-title":"Medical Care"},{"key":"3093_CR8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/oso\/9780195108248.001.0001","volume-title":"Cost-effectiveness in health and medicine","author":"MR Gold","year":"1996","unstructured":"Gold, M. R., Siegel, J. E., Russell, L. B., & Weinstein, M. C. (1996). Cost-effectiveness in health and medicine (pp. 25\u201354). USA: Oxford University Press."},{"key":"3093_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2016.00115","author":"M Jakovljevic","year":"2016","unstructured":"Jakovljevic, M., & Ogura, S. (2016). Health economics at the crossroads of centuries\u2014From the past to the future. Frontiers in Public Health. https:\/\/doi.org\/10.3389\/fpubh.2016.00115 .","journal-title":"Frontiers in Public Health"},{"key":"3093_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2017.00211","author":"M Jakovljevic","year":"2017","unstructured":"Jakovljevic, M., & Pejcic, A. V. (2017). Growth of global publishing output of health economics in the twenty-first century: A bibliographic insight. Frontiers in Public Health. https:\/\/doi.org\/10.3389\/fpubh.2017.00211 .","journal-title":"Frontiers in Public Health"},{"key":"3093_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2018.00368","author":"M Jakovljevic","year":"2018","unstructured":"Jakovljevic, M., Verhaeghe, N., & Souliotis, K. (2018). Editorial: Challenges of pharmacoeconomics in global health arena. Frontiers in Public Health. https:\/\/doi.org\/10.3389\/fpubh.2018.00368 .","journal-title":"Frontiers in Public Health"},{"issue":"1","key":"3093_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1586\/14737167.1.1.1","volume":"1","author":"JA Mauskopf","year":"2001","unstructured":"Mauskopf, J. A. (2001). Why study pharmacoeconomics? Expert Review of Pharmacoeconomics & Outcomes Research, 1(1), 1\u20133. https:\/\/doi.org\/10.1586\/14737167.1.1.1 .","journal-title":"Expert Review of Pharmacoeconomics & Outcomes Research"},{"issue":"2","key":"3093_CR13","first-page":"133","volume":"35","author":"WF McGhan","year":"1978","unstructured":"McGhan, W. F., Rowland, C. R., & Bootman, J. L. (1978). Cost-benefit and cost-effectiveness: Methodologies for evaluating innovative pharmaceutical services. American Journal of Hospital Pharmacy., 35(2), 133\u2013140.","journal-title":"American Journal of Hospital Pharmacy."},{"key":"3093_CR14","volume-title":"Cost-benefit analysis: Theory and application","author":"TF Nas","year":"2016","unstructured":"Nas, T. F. (2016). Cost-benefit analysis: Theory and application (2nd ed.). London: Lexington Books.","edition":"2"},{"issue":"1","key":"3093_CR15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.jval.2013.08.2291","volume":"17","author":"SD Sullivan","year":"2014","unstructured":"Sullivan, S. D., Mauskopf, J. A., Augustovski, F., Caro, J. J., Lee, K. M., Minchin, M., et al. (2014). Budget impact analysis-principles of good practice: report of the ISPOR 2012 budget impact analysis good practice II task force. Value in Health, 17(1), 5\u201314.","journal-title":"Value in Health"},{"issue":"1","key":"3093_CR16","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.healthpol.2005.07.016","volume":"77","author":"R Tarricone","year":"2006","unstructured":"Tarricone, R. (2006). Cost-of-illness analysis: What room in health economics? Health Policy, 77(1), 51\u201363. https:\/\/doi.org\/10.1016\/j.healthpol.2005.07.016 .","journal-title":"Health Policy"},{"issue":"4","key":"3093_CR17","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1017\/S0266462300008461","volume":"5","author":"GW Torrance","year":"1989","unstructured":"Torrance, G. W., & Feeny, D. (1989). Utilities and quality-adjusted life years. International Journal of Technology Assessment in Health Care, 5(4), 559\u2013575.","journal-title":"International Journal of Technology Assessment in Health Care"},{"issue":"1 Pt 2","key":"3093_CR18","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1177\/10600280870211P216","volume":"21","author":"RJ Townsend","year":"1987","unstructured":"Townsend, R. J. (1987). Postmarketing drug research and development. Drug lntelligence and Clinical Pharmacy, 21(1 Pt 2), 134\u2013136.","journal-title":"Drug lntelligence and Clinical Pharmacy"},{"issue":"6","key":"3093_CR19","doi-asserted-by":"publisher","first-page":"609","DOI":"10.2165\/00019053-200119060-00001","volume":"19","author":"P Trueman","year":"2001","unstructured":"Trueman, P., Drummond, M., & Hutton, J. (2001). Developing guidance for budget impact analysis. Pharmacoeconomics, 19(6), 609\u2013621. https:\/\/doi.org\/10.2165\/00019053-200119060-00001 .","journal-title":"Pharmacoeconomics"},{"key":"3093_CR20","volume-title":"Theory of games and economic behavior","author":"J Neumann von","year":"1944","unstructured":"von Neumann, J., & Morgenstern, O. (1944). Theory of games and economic behavior. Princeton, NJ: Princeton University Press."},{"issue":"2","key":"3093_CR21","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.jhealeco.2012.03.002","volume":"31","author":"A Wagstaff","year":"2012","unstructured":"Wagstaff, A., & Culyer, A. J. (2012). Four decades of health economics through a bibliometric lens. Journal of Health Economics, 31(2), 406\u2013439. https:\/\/doi.org\/10.1016\/j.jhealeco.2012.03.002 .","journal-title":"Journal of Health Economics"}],"container-title":["Scientometrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11192-019-03093-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11192-019-03093-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11192-019-03093-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T12:01:20Z","timestamp":1721131280000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11192-019-03093-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,30]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["3093"],"URL":"https:\/\/doi.org\/10.1007\/s11192-019-03093-0","relation":{},"ISSN":["0138-9130","1588-2861"],"issn-type":[{"type":"print","value":"0138-9130"},{"type":"electronic","value":"1588-2861"}],"subject":[],"published":{"date-parts":[[2019,3,30]]},"assertion":[{"value":"29 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}